pe22-28 peptide PE 22-28 has a high potential for use in the treatment of depression - PE-22-28peptidereviews is a 7 amino-acid peptide PE22-28 Peptide: Understanding Its Role as a TREK-1 Inhibitor and Its Research Potential

PE-22-28peptidereviews The dominant search intent for "pe22-28 peptide" is informational, focusing on understanding what the peptide is, its potential benefits, its mechanism of action, and its research applications, particularly concerning mood regulation, cognitive function, and neuroprotection.

Tier 1 Entities & Phrases:

* Core Topic: PE22-28 peptide

* Key Function/Mechanism: TREK-1 inhibitor, potassium channel subfamily K member 2 inhibitor

* Origin/Nature: Synthetic derivative of spadin, 7 amino-acid peptide, heptapeptide

* Primary Research Areas: Mood regulation, depression, anxiety, cognitive function, neurogenesis, synaptogenesis, stress resilience

Tier 2 Entities & Phrases:

* Potential Benefits/Applications: Wound healing, tissue regeneration, stroke recovery, neurodegenerative diseases, learning enhancement

* Related Peptides/Concepts: Galanin neuropeptide, spadin, analogs

* Research Context: Research peptide, biological research, not intended for human consumption (implied by research use only)

* Technical Details: IC50 value (0.PE22-2812 nM)

* Related Searches: PE-22-28 peptide dosage, PE-22-28 peptide buy, PE-22-28 benefits, PE-22-28 vs Selank

Tier 3 Entities & Phrases:

* Specific CAS numbers, supplier names, explicit mentions of "ordering," "buying," or "reviews" unless they directly inform about research status or availability for research.PE 22-28 alsois a 7 amino-acid peptidethat is used as a core sequence for preparing analogs by chemical modifications and also by substitution of amino-acids. Mentions of specific dates or years unless crucial for contextPE 22-28 Supplier | CAS 1801959-12-5 - Tocris Bioscience.

---

The PE22-28 peptide is an emerging synthetic compound derived from the naturally occurring peptide spadin, garnering significant attention in scientific research. As a seven-amino-acid peptide, PE22-28 functions primarily as a potent inhibitor of the TREK-1 potassium channel. This specific mechanism is believed to underlie its potential therapeutic applications, particularly in areas related to mood regulation, cognitive function, and neuroprotectionPE22-28 biochemical | PE 22-28 Biochemical. Researchers are actively exploring its capacity to influence mood, reduce anxiety, and promote neurogenesis, positioning it as a subject of interest for conditions such as depression and cognitive decline.

The Mechanism of Action: Targeting TREK-1 Channels

At the heart of PE22-28's observed effects is its action as a TREK-1 inhibitor. TREK-1, a member of the potassium channel subfamily K member 2, plays a role in neuronal excitability and plasticity. By inhibiting TREK-1, PE22-28 can modulate neuronal firing patternsPE-22-28 Peptide: Benefits, Dosage & Side Effects. Studies indicate a low IC50 value of 0.12 nM for PE22-28's inhibition of TREK-1, suggesting high potency. This targeted inhibition is thought to contribute to its antidepressant-like effects and its ability to enhance cognitive processes, such as learning and memory, by influencing synaptic function and neurogenesis.

Investigated Benefits and Research Applications

The research surrounding the PE22-28 peptide points to a multifaceted potential, with a strong emphasis on neurological and psychological well-being2024年11月22日—PE-22-28 benefits includeenhancing cognitive function, reducing anxiety, and promoting neuroprotection. This peptide also supports mood stabilization.. Its capacity to influence mood regulation and treat neural inflammation is a key area of investigation. Early research suggests PE22-28 may be beneficial in addressing symptoms of depression and anxiety, potentially by promoting neurogenesis and synaptogenesis, processes critical for brain health and functionPE 22-28 (8mg) - peptide with antidepressant properties.. Beyond mood, PE22-28 is also being studied for its role in cognitive enhancement, potentially improving memory, decision-making, and overall focusPE 22-28 has a high potential for use in the treatment of depression, regulation of neuro- and synaptogenesis, with increased efficacy and rapid action.. Furthermore, its potential to accelerate wound healing by stimulating collagen production and enhancing tissue regeneration has also been noted in research contexts. The peptide's synthetic nature makes it a valuable tool for researchers designing analogs with modified stability and efficacy, using PE22-28 as a core sequence for further exploration.

Research Status and Considerations

It is crucial to understand that PE22-28 is primarily a research peptide2023年10月10日—PE-22-28, a synthetic derivative of the naturally occurring peptide spadin, is garnering significant attention in research studies.. While its potential benefits are being actively investigated, it is not approved for human consumption or therapeutic use outside of controlled research settings. Suppliers typically offer PE22-28 strictly for research purposes.Fighting against depression with TREK-1 blockers Studies often involve laboratory models, such as rodent models of ischemia, where PE22-28 has shown promise in reducing apoptotic cell death.PE 22-28 (7868) by Tocris, Part of Bio-Techne The development of PE22-28 as a synthetic derivative of spadin highlights ongoing efforts to harness the properties of natural peptides for more targeted and effective research tools. As research progresses, further insights into its long-term effects, optimal dosing protocols, and specific applications will likely emerge.